Jorge A. Gómez-García

Janaína Mendes-Laureano, Jorge A. Gómez-García, Alejandro Guerrero-López et al.

The screening of Parkinson's Disease (PD) through speech is hindered by a notable lack of publicly available datasets in different languages. This fact limits the reproducibility and further exploration of existing research. To address this gap, this manuscript presents the NeuroVoz corpus consisting of 112 native Castilian-Spanish speakers, including 58 healthy controls and 54 individuals with PD, all recorded in ON state. The corpus showcases a diverse array of speech tasks: sustained vowels; diadochokinetic tests; 16 Listen-and-Repeat utterances; and spontaneous monologues. The dataset is also complemented with subjective assessments of voice quality performed by an expert according to the GRBAS scale (Grade/Roughness/Breathiness/Asthenia/Strain), as well as annotations with a thorough examination of phonation quality, intensity, speed, resonance, intelligibility, and prosody. The corpus offers a substantial resource for the exploration of the impact of PD on speech. This data set has already supported several studies, achieving a benchmark accuracy of 89% for the screening of PD. Despite these advances, the broader challenge of conducting a language-agnostic, cross-corpora analysis of Parkinsonian speech patterns remains open.

Julian D. Arias-Londoño, Jorge A. Gomez-Garcia, Laureano Moro-Velazquez et al.

Current standard protocols used in the clinic for diagnosing COVID-19 include molecular or antigen tests, generally complemented by a plain chest X-Ray. The combined analysis aims to reduce the significant number of false negatives of these tests, but also to provide complementary evidence about the presence and severity of the disease. However, the procedure is not free of errors, and the interpretation of the chest X-Ray is only restricted to radiologists due to its complexity. With the long term goal to provide new evidence for the diagnosis, this paper presents an evaluation of different methods based on a deep neural network. These are the first steps to develop an automatic COVID-19 diagnosis tool using chest X-Ray images, that would additionally differentiate between controls, pneumonia or COVID-19 groups. The paper describes the process followed to train a Convolutional Neural Network with a dataset of more than 79,500 X-Ray images compiled from different sources, including more than 8,500 COVID-19 examples. For the sake of evaluation and comparison of the models developed, three different experiments were carried out following three preprocessing schemes. The aim is to evaluate how preprocessing the data affects the results and improves its explainability. Likewise, a critical analysis is carried out about different variability issues that might compromise the system and the effects on the performance. With the employed methodology, a 91.5% classification accuracy is obtained, with a 87.4% average recall for the worst but most explainable experiment, which requires a previous automatic segmentation of the lungs region.